register

News & Trends - Pharmaceuticals

Grant call open for research on chronic fatigue syndrome

Health Industry Hub | October 23, 2019 |

The Morrison Government is calling for proposals for $3 million in research to better understand the causes and improve diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).

Today’s opening of the National Health and Medical Research Council (NHMRC) competitive Targeted Call for Research (TCR) is designed to help stimulate quality collaborative research in this area.

ME/CFS is a complex condition that leaves patients with persistent disabling fatigue, particularly after general activity. Other symptoms that range from mild to severe include muscle and joint pain, as well as headaches. Little is known about its causes, which makes diagnosis and treatment difficult.

This TCR enables Australian researchers to identify approaches that may assist patients presenting with ME/CFS symptoms to be accurately diagnosed and treated.

It will also provide the opportunity to develop a scientifically valid, evidence-based understanding of the pathophysiology and causes of ME/CFS and its impacts.

This TCR is in addition to the Government’s announcement on 20 September 2019 of funding for a health economics study of the impacts and costs associated with ME/CFS, funded through the Medical Research Future Fund’s Targeted Health System and Community Organisation Research Program.

Applications for funding will be open from 23 October 2019 to 29 January 2020.

More information, including the grant opportunity guidelines, will be available on www.grants.gov.au.

You may also like Pharmacist prescribing on the way


ESG

Surgeons lead push for $1.5 million hospital sustainability project

Surgeons lead push for $1.5 million hospital sustainability project

Health Industry Hub | October 23, 2024 |

ESG: Australia’s healthcare sector contributes 7% of the country’s total emissions. The Royal Australasian College of Surgeons (RACS) has joined […]

More


News & Trends - MedTech & Diagnostics

AI-assisted colonoscopy boosts polyp and adenoma detection

AI-assisted colonoscopy boosts polyp and adenoma detection

Health Industry Hub | October 23, 2024 |

MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]

More


News & Trends - Pharmaceuticals

'Every day of delay is costing Australian lives', says Rare Cancers Australia CEO

‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO

Health Industry Hub | October 23, 2024 |

Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]

More


News & Trends - Pharmaceuticals

Government's silence on Senate report leaves cancer patients in limbo

Government’s silence on Senate report leaves cancer patients in limbo

Health Industry Hub | October 23, 2024 |

Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]

More


This content is copyright protected. Please subscribe to gain access.